SCHEMBL6801469

SCHEMBL6801469

COc1ccc(C(O)(C#N)CC#N)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 1/20 0.41
ALDH1A1 P00352 5/20 0.40
GAA P10253 1/20 0.40
HSD17B10 Q99714 2/20 0.39
CASP1 P29466 1/20 0.39
MAPT P10636 3/20 0.39
APEX1 P27695 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
KDM4E B2RXH2 2/20 0.39
HPGD P15428 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
NFKB1 P19838 1/20 0.39
BLM P54132 1/20 0.39
PMP22 Q01453 1/20 0.39
LMNA P02545 3/20 0.38
TDP1 Q9NUW8 2/20 0.38
ALOX15 P16050 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10616215 0.85 ESR1 (0.35) HSD17B10CASP1
SCHEMBL8558744 0.82 LMNA (0.44) AOC3ALDH1A1GAAHSD17B10CASP1
Acetonitrile SCHEMBL8561616 0.79 LMNA (0.42) AOC3ALDH1A1GAAHSD17B10MAPT
SCHEMBL7583086 0.77 ALDH1A1 (0.43) AOC3ALDH1A1GAAHSD17B10CASP1
SCHEMBL8610666 0.76 ATM (0.39) ALDH1A1MAPTNPSR1CYP1A2CYP3A4
SCHEMBL20782023 0.73 APP (0.47) AOC3ALDH1A1GAAHSD17B10MAPT
SCHEMBL3524113 0.73 CA1 (0.52) ALDH1A1GAAMAPTAPEX1NPSR1
SCHEMBL5469510 0.72 HSD17B10 (0.45) AOC3ALDH1A1GAAHSD17B10CASP1
SCHEMBL11845532 0.72 HSD17B10 (0.65) AOC3ALDH1A1GAAHSD17B10CASP1
SCHEMBL9520196 0.72 ALDH1A1 (0.49) AOC3ALDH1A1TSHRLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6784295-B2 CARRIED OUT IN THE PRESENCE OF AN INORGANIC BASE OR ORGANIC NITROGEN BASE AND A PALLADIUM COMPLEX CATALYST CONTAINING SECONDARY MONOPHOSPHINES WITH ALIPHATIC, BRANCHED OR CYCLIC SUBSTITUENTS AS LIGANDS SOLVIAS AG (CH) 2004-08-31 US disclosed
US-20030181688-A1 Coupling of nucleophiles, vinyl compounds or CO with water, alcohols or amines to organic compounds INDOLESE ADRIANO (CH) 2003-09-25 US disclosed
EP-1132361-B1 Coupling of nucleophiles, vinyl compounds or CO with water, alcohols or amines to organic compounds SOLVIAS AG (CH) 2003-05-14 EP disclosed
US-6548684-B2 Using monophosphine palladium complex catalyst SOLVIAS AG (SE) 2003-04-15 US disclosed
US-20010037042-A1 Coupling of nucleophiles, vinyl compounds or CO with water, alcohols or amines to organic compounds SOLVIAS AG (CH) 2001-11-01 US disclosed
EP-1132361-A1 Coupling of nucleophiles, vinyl compounds or CO with water, alcohols or amines to organic compounds Solvias AG (CH) 2001-09-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010037042-A1 Coupling of nucleophiles, vinyl compounds or CO with water, alcohols or amines to organic compounds ADH1C, ALKBH3, PNMT AOC3 4/4885ALDH1A1 1512/4885GAA 3753/4885
US-20030181688-A1 Coupling of nucleophiles, vinyl compounds or CO with water, alcohols or amines to organic compounds ADH1C, ALKBH3, PNMT AOC3 4/4885ALDH1A1 1512/4885GAA 3753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.